Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy

被引：0
|
作者：
Melissa Krystel-Whittemore
Jin Xu
Edi Brogi
Katia Ventura
Sujata Patil
Dara S. Ross
Chau Dang
Mark Robson
Larry Norton
Monica Morrow
Hannah Y. Wen
机构：
[1] Massachusetts General Hospital,Department of Pathology
[2] Memorial Sloan Kettering Cancer,Department of Pathology
[3] Memorial Sloan Kettering Cancer,Department of Epidemiology and Biostatistics
[4] Memorial Sloan Kettering Cancer,Department of Medicine
[5] Memorial Sloan Kettering Cancer,Department of Surgery
来源：
Breast Cancer Research and Treatment | 2019年 / 177卷
关键词：
Pathologic complete response; HER2 assessment; Neoadjuvant systemic therapy; HER2-positive breast cancer; Human epidermal growth factor receptor 2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：61 / 66
页数：5
相关论文
共 50 条
  • [1] Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Krystel-Whittemore, Melissa
    Xu, Jin
    Brogi, Edi
    Ventura, Katia
    Patil, Sujata
    Ross, Dara S.
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Wen, Hannah Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (01) : 61 - 66
  • [2] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Takeo Fujii
    Takahiro Kogawa
    Jimin Wu
    Aysegul A Sahin
    Dian D Liu
    Mariana Chavez-MacGregor
    Sharon H Giordano
    Akshara Raghavendra
    Rushmy K Murthy
    Debu Tripathy
    Yu Shen
    Jose-Miguel Yamal
    Naoto T Ueno
    British Journal of Cancer, 2017, 116 : 509 - 514
  • [3] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Fujii, Takeo
    Kogawa, Takahiro
    Wu, Jimin
    Sahin, Aysegul A.
    Liu, Dian D.
    Chavez-MacGregor, Mariana
    Giordano, Sharon H.
    Raghavendra, Akshara
    Murthy, Rushmy K.
    Tripathy, Debu
    Shen, Yu
    Yamal, Jose-Miguel
    Ueno, Naoto T.
    BRITISH JOURNAL OF CANCER, 2017, 116 (04) : 509 - 514
  • [4] Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'
    Altundag, Kadri
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e10 - e10
  • [5] Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’
    Kadri Altundag
    British Journal of Cancer, 2017, 116 : e10 - e10
  • [6] Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
    Chen, Hai-Long
    Chen, Qiang
    Deng, Yong-Chuan
    MEDICINE, 2021, 100 (44)
  • [7] Reply to 'Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''
    Fujii, Takeo
    Ueno, Naoto T.
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e11 - e11
  • [8] Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’’
    Takeo Fujii
    Naoto T Ueno
    British Journal of Cancer, 2017, 116 : e11 - e11
  • [9] Predictors of pathologic complete response in HER2 positive breast cancer patients treated with neoadjuvant targeted therapy
    Rosario, Mariela Huerta
    Sahoo, Sunati
    CANCER RESEARCH, 2020, 80 (04)
  • [10] HER2 equivocal breast cancer and neoadjuvant therapy: Is response similar to HER2-positive or HER2-negative tumors?
    Landmann, Alessandra
    Farrugia, Daniel J.
    Diego, Emilia
    Bonaventura, Marguerite
    Soran, Atilla
    Johnson, Ronald
    Dabbs, David J.
    Clark, Beth
    Brufsky, Adam
    Davidson, Nancy E.
    Lembersky, Barry C.
    Jankowitz, Rachel Catherine
    Puhalla, Shannon
    Ahrendt, Gretchen M.
    McAuliffe, Priscilla F.
    Bhargava, Rohit
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345